Onterris, Inc. (ONT) SEC Filings & Earnings Calls
EquiReason read 13 Onterris, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-10-08 — Director Janet Risi Field resigned for personal reasons, effective immediately, with no disagreement with the company..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 520.8M
- P/E TTM
- —
- Dividend yield
- 0.3%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
8 Oct 20268-K · 5.02Director Janet Risi Field resigned for personal reasons, effective immediately, with no disagreement with the company.open
Risks flagged
Board composition change may signal governance instability, but resignation is personal and non-disruptive.
“Resignation effective immediately, but no disagreement with company operations, policies, or practices.”
6 Aug 202610-QQ2 2026 revenue declined 20.4% YoY, operating income fell 56.8%, and operating cash flow turned negative.earningsopen
Figures in the filing · each found in the filing text
| Revenues · Q2-2026 | $187M | -20% y/y |
| Net income (loss) · Q2-2026 | $1M | -93% y/y |
| Net cash (used in) provided by operating activities · H1-2026 | $-5M | -120% y/y |
| Remaining unsatisfied performance obligations · 2026-06-30 | $50M | -27% y/y |
| Consolidated total leverage ratio · 2026-06-30 | $3.20 | +28% y/y |
Risks flagged
Revenue Decline and Customer Concentration Loss
“Revenues $ 186,661 $ 234,543” · word for word
Negative Operating Cash Flow
“Net cash (used in) provided by operating activities $ (5,481) $ 27,398” · word for word
Increased Leverage
“As of June 30, 2026 and December 31, 2025, the Company’s consolidated total leverage ratio (as defined in the 2025 Credit Facility) was 3.2 times and 2.5 times, respectively” · word for word
5 Aug 20268-K · 1.01, 3.03, 5.03, 8.01Onterris adopted a shareholder rights plan (poison pill) with a 15% trigger, expiring August 4, 2027, to deter hostile takeovers.open
Risks flagged
Potential takeover threat or activist pressure; poison pill may entrench management.
“Rights Agreement adopted to deter accumulations of 15% or more”
5 Aug 20268-K · 2.02, 7.01Q2 2026 revenue $186.7M (-20% YoY), net income $1.4M vs $18.4M, Adj EBITDA $31.9M (-19% YoY). Cut FY2026 revenue guidance to $740-790M from $840-900M and Adj EBITDA to $117-120M from $125-130M due to low emergency response revenue.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $187M | -20% y/y |
| Net income · Q2-2026 | $1M | -92% y/y |
| Diluted EPS · Q2-2026 | $0.04 | -90% y/y |
| Adjusted Net Income · Q2-2026 | $20M | -28% y/y |
| Diluted Adjusted EPS · Q2-2026 | $0.51 | -15% y/y |
| Consolidated Adjusted EBITDA · Q2-2026 | $32M | -19% y/y |
| Consolidated Adjusted EBITDA margin · Q2-2026 | 17.1% | |
| Income from operations · Q2-2026 | $7M | -56% y/y |
Guidance
FY2026 revenue cut to $740-790M from $840-900M; FY2026 Consolidated Adj EBITDA cut to $117-120M from $125-130M; Q3 2026 revenue expected $190-210M with Adj EBITDA margin 17-18%; FY2026 operating cash flow conversion 60% of Adj EBITDA; H2 2026 operating cash flow $70-80M; year-end leverage ratio ~2.5x
Cut FY2026 guidance due to low emergency response revenue, but underlying business growing with margin expansion and stable cash flow expectations
Risks flagged
High dependence on unpredictable environmental emergency response revenue; historically low activity causing significant revenue decline
“Environmental emergency response revenue declined by $37.7 million; guidance cut primarily due to lower emergency response revenue”
Revenue guidance cut by ~12% at midpoint; Adj EBITDA guidance cut by ~8%
“Updated 2026 revenue guidance of $740.0 million to $790.0 million, from $840.0 million to $900.0 million; Updated 2026 Consolidated Adjusted EBITDA guidance of $117.0 million to $120.0 million, from $125.0 million to $130.0 million”
7 May 202610-QQ1 2026 results: revenue declined 5.2% YoY, operating loss narrowed, but operating cash flow turned negative.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $169M | -5% y/y |
| Net Loss · Q1-2026 | $-13M | +35% y/y |
| Operating Cash Flow · Q1-2026 | $-12M | -311% y/y |
| Free Cash Flow · Q1-2026 | $-17M |
Risks flagged
Negative operating cash flow
“Net cash (used in) provided by operating activities ($11,637) (in thousands) for Q1 2026 vs $5,504 (in thousands) for Q1 2025.” · word for word
Revenue decline
“Revenues $168,518 (in thousands) for Q1 2026 vs $177,834 (in thousands) for Q1 2025.”
High leverage
“Total leverage ratio 2.8x as of March 31, 2026.”
6 May 20268-K · 2.02, 7.01Revenue $168M (-5% y/y); Net loss attributable to common stockholders $-13M (+34% y/y); Adjusted Net Income $5M (-21% y/y); Guidance: FY2026 adjusted EBITDA $125-130M; revenue $840-900M; Q2 revenue $190-210Mearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $169M | -5% y/y |
| Net loss attributable to common stockholders · Q1-2026 | $-13M | +35% y/y |
| Adjusted Net Income · Q1-2026 | $5M | -21% y/y |
| Adjusted EBITDA · Q1-2026 | $18M | -6% y/y |
| Adjusted EBITDA margin · Q1-2026 | 10.6% | |
| Diluted LPS · Q1-2026 | $-0.35 | +45% y/y |
| Adjusted EPS · Q1-2026 | $0.12 | +71% y/y |
| Operating cash flow · Q1-2026 | $-12M | |
| Free cash flow · Q1-2026 | $-17M | |
| Leverage · Q1-2026 | $2.80 |
Guidance
FY2026 adjusted EBITDA $125-130M; revenue $840-900M; Q2 revenue $190-210M
Full-year guidance reiterated with ~10% EBITDA growth at midpoint; Q2 outlook provided; management expresses commitment to cash conversion and bolt-on acquisitions.
Risks flagged
Negative operating and free cash flow in Q1 due to bonus payments; leverage at 2.8x.
“$(11.6) million of operating cash flow and $(17.2) million of Free cash flow; 2.8x leverage” · word for word
Revenue decline driven by lower emergency response revenue, which is inherently volatile.
“lower emergency response revenue” · word for word
24 Mar 2026DEF 14AProxy statement for 2026 annual meeting; discloses executive compensation structure tied to adjusted EBITDA, strong shareholder support, and plans for future LTIP.open
Figures in the filing · each found in the filing text
| Adjusted EBITDA · FY2025 | $116M | +21% y/y |
| Net Income · FY2025 | $-2M |
25 Feb 20268-K · 2.02, 7.01Revenue $830M (+19% y/y); Free cash flow $87M; Operating cash flow $108M; Guidance: 2026 revenue guidance $840M-$900M (midpoint ~$870M) vs 2025 revenue $830.5M; 2026 Adjusted EBITDA guidance $125M-$130M vs 2025 $116.2Mearningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $831M | +19% y/y |
| Free cash flow · FY2025 | $87M | |
| Operating cash flow · FY2025 | $108M | |
| Net loss · FY2025 | $-800000.00 | |
| Consolidated Adjusted EBITDA · FY2025 | $116M | +21% y/y |
| Consolidated Adjusted EBITDA as a percentage of revenue · FY2025 | 14.0% | |
| 2026 Adjusted EBITDA margin guidance · FY2026 | 15.0% | |
| Leverage · Q4-2025 | $2.50 |
Guidance
2026 revenue guidance $840M-$900M (midpoint ~$870M) vs 2025 revenue $830.5M; 2026 Adjusted EBITDA guidance $125M-$130M vs 2025 $116.2M
Raised guidance for 2026 with revenue growth, margin expansion, and resumption of acquisitions; strong cash flow and balance sheet
Risks flagged
Dependence on regulatory volatility as tailwind; potential policy shifts could impact demand
“US regulatory volatility would create more tailwinds than headwinds” · word for word
Acquisition execution risk; restarting M&A after pause may lead to integration challenges
“Plan to restart smaller, bolt-on and highly accretive acquisitions over the course of 2026” · word for word
20 Jan 20268-K · 5.02Annual base salary $525,000.00; One-time equity grant $500,000.00open
Figures in the filing · each found in the filing text
| Annual base salary | $525000.00 | |
| One-time equity grant | $500000.00 |
5 Nov 202510-QMontrose Environmental reported Q3 2025 revenue of $224.9M (+25.9% YoY) and net income of $8.4M vs loss of $10.6M YoY; strong operational improvement.earningsopen
Figures in the filing · each found in the filing text
| Total Revenues · Q3-2025 | $225M | +26% y/y |
| Net Income · Q3-2025 | $8M | |
| Operating Cash Flow · 9M-2025 | $56M | |
| Cash and Cash Equivalents · 2025-09-30 | $7M | |
| Gross Profit · Q3-2025 | $89M |
Risks flagged
Low cash balance relative to debt
“Cash, cash equivalents and restricted cash $6,736 at September 30, 2025; Total debt $313,624”
Customer concentration
“The Company had one customer that exceeded 10.0% of its gross receivables as of September 30, 2025”
Integration risk from acquisitions
“strategic acquisitions remain a core part of the Company's growth strategy” · word for word
4 Nov 20258-K · 2.02, 7.01Revenue $225M (+26% y/y); Net income attributable to common stockholders $8M; Adjusted Net Income $14M; Guidance: FY2025 revenue guidance raised to $810M-$830M (18% growth at midpoint); Adjusted EBITDA to $112M-$118M (20% growth at midpointearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $225M | +26% y/y |
| Net income attributable to common stockholders · Q3-2025 | $8M | |
| Adjusted Net Income · Q3-2025 | $14M | |
| Consolidated Adjusted EBITDA · Q3-2025 | $34M | +19% y/y |
| Consolidated Adjusted EBITDA margin · Q3-2025 | 15.0% | |
| Operating cash flow (YTD) · 9M-2025 | $56M | |
| Preliminary FY2026 Adjusted EBITDA outlook · FY2026 | $125M | |
| Leverage ratio · Q3-2025 | $2.70 | |
| Series A-2 Preferred Stock redeemed · Q3-2025 | $62M | |
| EPS · Q3-2025 | $0.21 |
Guidance
FY2025 revenue guidance raised to $810M-$830M (18% growth at midpoint); Adjusted EBITDA to $112M-$118M (20% growth at midpoint)
Third consecutive guidance raise; strong organic growth across all segments; operating leverage driving margin accretion; preliminary FY2026 outlook indicates continued momentum.
Risks flagged
Adjusted Net Income decreased to $14.2M from $19.1M prior year due to higher income tax expense.
“Adjusted Net Income and Adj EPS were $14.2 million and $0.36, respectively, compared to the prior year quarter... $19.1 million and $0.41... decreased primarily due to higher income tax expense”
Onterris, Inc. — questions
- What did Onterris, Inc. file recently?
- 13 SEC filings in the last 12 months. Latest: 8-K on 2026-10-08 — Director Janet Risi Field resigned for personal reasons, effective immediately, with no disagreement with the company.
Every figure on this page comes from Onterris, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.